Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76901 - 76925 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tamoxifen	Approved Investigational	RUNX1T1	862	upregulated	Tamoxifen results in increased expression of RUNX1T1 mRNA	8q21.3	A21116
Tamoxifen	Approved Investigational	SAFB	6294	upregulated	Tamoxifen results in increased expression of SAFB mRNA	19p13.3	A21112
Tamoxifen	Approved Investigational	SEMA4B	10509	downregulated	Tamoxifen results in decreased expression of SEMA4B mRNA	15q25	A21112
Tamoxifen	Approved Investigational	SERPINA3	12	downregulated	Tamoxifen results in decreased expression of SERPINA3 mRNA	14q32.13	A20430
Tamoxifen	Approved Investigational	SERPINA3	12	upregulated	Tamoxifen results in increased expression of SERPINA3 mRNA	14q32.13	A20438 A20430
Tamoxifen	Approved Investigational	SERPINB2	5055	downregulated	Tamoxifen results in decreased expression of SERPINB2 mRNA	18q21.33-q22.1	A21168
Tamoxifen	Approved Investigational	SERPINB9	5272	upregulated	Tamoxifen analog results in increased expression of SERPINB9 mRNA	6p25.2	A21364
Tamoxifen	Approved Investigational	SF3A2	8175	downregulated	Tamoxifen results in decreased expression of SF3A2 mRNA	19p13.3	A24383
Tamoxifen	Approved Investigational	SLC2A3	6515	downregulated	Tamoxifen results in decreased expression of SLC2A3 mRNA	12p13.31	A20438 A20646
Tamoxifen	Approved Investigational	SLC2A4	6517	downregulated	Tamoxifen results in decreased expression of SLC2A4 mRNA	17p13.1	A21264
Tamoxifen	Approved Investigational	SLC2A4	6517	upregulated	Tamoxifen results in increased expression of SLC2A4 mRNA	17p13.1	A21264
Tamoxifen	Approved Investigational	SLC3A2	6520	upregulated	Tamoxifen results in increased expression of SLC3A2 mRNA	11q12.3	A3616
Tamoxifen	Approved Investigational	SLC4A8	9498	upregulated	Tamoxifen results in increased expression of SLC4A8 mRNA	12q13.13	A21164
Tamoxifen	Approved Investigational	SLC7A5	8140	downregulated	Tamoxifen results in decreased expression of SLC7A5 mRNA	16q24.2	A24384
Tamoxifen	Approved Investigational	SOD2	6648	upregulated	Tamoxifen results in increased expression of SOD2 mRNA	6q25.3	A3616
Tamoxifen	Approved Investigational	SPATA13	221178	upregulated	Tamoxifen results in increased expression of SPATA13 mRNA	13q12.12	A21164
Tamoxifen	Approved Investigational	SPATA2	9825	upregulated	Tamoxifen results in increased expression of SPATA2 mRNA	20q13.13	A24383
Tamoxifen	Approved Investigational	SPHK1	8877	upregulated	Tamoxifen results in increased expression of SPHK1 mRNA	17q25.2	A3616
Tamoxifen	Approved Investigational	SPP1	6696	upregulated	Tamoxifen results in increased expression of SPP1 mRNA	4q22.1	A24384
Tamoxifen	Approved Investigational	ST3GAL2	6483	upregulated	Tamoxifen results in increased expression of ST3GAL2 mRNA	16q22.1	A21112
Tamoxifen	Approved Investigational	STAB1	23166	upregulated	Tamoxifen results in increased expression of STAB1 mRNA	3p21.1	A21115
Tamoxifen	Approved Investigational	STAT1	6772	upregulated	Tamoxifen results in increased expression of STAT1 mRNA	2q32.2	A24384
Tamoxifen	Approved Investigational	STC2	8614	downregulated	Tamoxifen results in decreased expression of STC2 mRNA	5q35.2	A3616
Tamoxifen	Approved Investigational	STX18	53407	downregulated	Tamoxifen results in decreased expression of STX18 mRNA	4p16.3-p16.2	A24383
Tamoxifen	Approved Investigational	SYNGR4	23546	upregulated	Tamoxifen results in increased expression of SYNGR4 mRNA	19q13.33	A24383

Displaying entries 76901 - 76925 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability